TY - JOUR
T1 - Expression profiling in multistage hepatocarcinogenesis
T2 - Identification of HSP70 as a molecular marker of early hepatocellular carcinoma
AU - Chuma, Makoto
AU - Sakamoto, Michiie
AU - Yamazaki, Ken
AU - Ohta, Tsutomu
AU - Ohki, Misao
AU - Asaka, Masahiro
AU - Hirohashi, Setsuo
N1 - Funding Information:
Abbreviations: HCC, hepatocellular carcinoma; AH, adenomatous hyperplasia; AAH, atypical adenomatous hyperplasia; HSP70, heat-shock protein 70; HCV, hepatitis C virus; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RT-PCR, reverse transcription polymerase chain reaction; mRNA, messenger RNA; HBV, hepatitis B virus. From the 1Pathology Division and 2Genomics Division, National Cancer Center Research Institute, Tokyo, and the 3Department of Gastroenterology and Hematology, Hokkaido University, Sapporo, Japan. Received July 3, 2002; accepted October 29, 2002. Supported by a Grant-in-Aid for the Second Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, and by the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research. M. Chuma is a recipient of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research. Address reprint requests to: Setsuo Hirohashi, M.D., Pathology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan. E-mail: shirohas@ncc.go.jp; fax: (81) 3-3248-2463. Copyright © 2003 by the American Association for the Study of Liver Diseases. 0270-9139/03/3701-0028$35.00/0 doi:10.1053/jhep.2003.50022
PY - 2003/1/1
Y1 - 2003/1/1
N2 - Hepatocellular carcinoma (HCC) associated with chronic liver disease evolves from precancerous lesions and early HCC to a progressed form. Nodule-in-nodule - type HCC (progressed HCC within early HCC) represents the transition from early to progressed HCC and, therefore, is useful in molecular genetic analysis of HCC progression during multistage carcinogenesis. We compared expression profiles among 7 early components and 7 progressed components of nodule-in-nodule - type HCCs and their corresponding noncancerous liver tissues with oligonucleotide array. Of the approximately 12,600 genes that were analyzed, a set of 95 genes provided a molecular signature that distinguished between early HCC components and their noncancerous liver tissues, and a set of 92 genes distinguished between progressed and early HCC components. Of these genes, the most abundantly up-regulated gene in early HCC components (P < .001) was heat-shock protein 70 (HSP70). Real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) confirmed this finding. Further immunohistochemical examination of HSP70 revealed its significant overexpression in early HCC compared with precancerous lesions (P < .001) and in progressed HCC compared with early HCC (P < .001). In conclusion, molecular signatures were dearly different in noncancerous liver tissue as compared with the early and progressed components of nodule-in-nodule - type HCC. Moreover, HSP70 could be a sensitive marker for the differential diagnosis of early HCC from precancerous lesion or noncancerous liver, a difficult distinction for pathologists due to very well differentiated histology with little atypia in early HCC.
AB - Hepatocellular carcinoma (HCC) associated with chronic liver disease evolves from precancerous lesions and early HCC to a progressed form. Nodule-in-nodule - type HCC (progressed HCC within early HCC) represents the transition from early to progressed HCC and, therefore, is useful in molecular genetic analysis of HCC progression during multistage carcinogenesis. We compared expression profiles among 7 early components and 7 progressed components of nodule-in-nodule - type HCCs and their corresponding noncancerous liver tissues with oligonucleotide array. Of the approximately 12,600 genes that were analyzed, a set of 95 genes provided a molecular signature that distinguished between early HCC components and their noncancerous liver tissues, and a set of 92 genes distinguished between progressed and early HCC components. Of these genes, the most abundantly up-regulated gene in early HCC components (P < .001) was heat-shock protein 70 (HSP70). Real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) confirmed this finding. Further immunohistochemical examination of HSP70 revealed its significant overexpression in early HCC compared with precancerous lesions (P < .001) and in progressed HCC compared with early HCC (P < .001). In conclusion, molecular signatures were dearly different in noncancerous liver tissue as compared with the early and progressed components of nodule-in-nodule - type HCC. Moreover, HSP70 could be a sensitive marker for the differential diagnosis of early HCC from precancerous lesion or noncancerous liver, a difficult distinction for pathologists due to very well differentiated histology with little atypia in early HCC.
UR - http://www.scopus.com/inward/record.url?scp=0037223571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037223571&partnerID=8YFLogxK
U2 - 10.1053/jhep.2003.50022
DO - 10.1053/jhep.2003.50022
M3 - Article
C2 - 12500205
AN - SCOPUS:0037223571
SN - 0270-9139
VL - 37
SP - 198
EP - 207
JO - Hepatology
JF - Hepatology
IS - 1
ER -